Timolol 0.005 MG/MG Ophthalmic Gel — RxCUI 313408
RxNorm drug concept · Semantic clinical drug
RxCUI 313408
Semantic clinical drug · SCD
● Current RxNorm concept 23 FDA products
25 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI313408
Official nameTimolol 0.005 MG/MG Ophthalmic Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astimolol 0.5 % Gel Forming Ophthalmic Solution; timolol maleate 0.5 % Ophthalmic Gel Forming Solution; timolol 0.5 % (as timolol maleate 6.8 MG/ML) Ophthalmic Gel
FDA products mapped23
Package NDCs mapped25
Reported Medicaid activity (SDUD)13,587 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Timolol Ophthalmic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's lowering the pressure inside your eye. Your eye constantly makes a fluid called aqueous humor, and if that fluid builds up too fast, pressure rises and can damage your optic n...
- What is timolol eye drops actually doing for my eyes?
- You're right, it has a slightly different consistency. Before each use, flip the closed bottle upside down and give it one shake — just once is enough. Then apply one drop into the...
- How do I use the gel-forming version correctly? It seems thicker than regular drops.
🕸️ Concept Web — How Timolol 0.005 MG/MG Ophthalmic Gel Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Timolol 0.005 MG/MG Ophthalmic Gel
RxCUI 313408 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Timolol
10600IN
-
Timolol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Timoptic
10601BN
-
Timoptic
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Timolol Ophthalmic Gel
376542SCDF -
Timolol Ophthalmic Product
1157100SCDG -
Timolol Ophthalmic Gel [Timoptic]
861419SBDF -
Timoptic Ophthalmic Product
1179067SBDG -
Ophthalmic Gel
316963DF -
Ophthalmic Product
1151135DFG
-
Timolol Ophthalmic Gel
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Timolol 0.005 MG/MG
340010SCDC -
Timolol 0.005 MG/MG Ophthalmic Gel [Timoptic]
861422SBD -
Timolol 0.005 MG/MG [Timoptic]
861421SBDC
-
Timolol 0.005 MG/MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Timolol 0.005 MG/MG
SCDC · 340010 -
Timolol Ophthalmic Gel
SCDF · 376542 -
Timolol Ophthalmic Product
SCDG · 1157100
Brand-Name Concepts
-
Timolol 0.005 MG/MG Ophthalmic Gel [Timoptic]
SBD · 861422 -
Timolol 0.005 MG/MG [Timoptic]
SBDC · 861421 -
Timolol Ophthalmic Gel [Timoptic]
SBDF · 861419 -
Timoptic Ophthalmic Product
SBDG · 1179067 -
Timoptic
BN · 10601
📦 FDA Products & Package NDCs
23 products · 25 package NDCs
25 package NDCs map to RxCUI 313408 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 24208-0814-25 | 1 BOTTLE, DISPENSING in 1 CARTON (24208-814-25) / 5 mL in 1... | Timoptic-XE | Bausch & Lomb Incorporated | 2016-05-31 |
| 24208-0816-05 | 1 BOTTLE, DISPENSING in 1 CARTON (24208-816-05) / 5 mL in 1... | Timoptic-XE | Bausch & Lomb Incorporated | 2016-05-31 |
| 25021-0008-05 | 1 BOTTLE in 1 CARTON (25021-008-05) / 5 mL in 1 BOTTLE | Timolol Maleate | Sagent Pharmaceuticals | 2026-01-15 |
| 25021-0009-05 | 1 BOTTLE in 1 CARTON (25021-009-05) / 5 mL in 1 BOTTLE | Timolol Maleate | Sagent Pharmaceuticals | 2026-01-15 |
| 43598-0747-11 | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE | Timolol Maleate Ophthalmic Gel Forming Solution 0.25% | Dr. Reddy's Laboratories, Inc. | 2022-11-15 |
| 43598-0748-11 | 1 BOTTLE in 1 CARTON (43598-748-11) / 5 mL in 1 BOTTLE | Timolol Maleate Ophthalmic Gel Forming Solution 0.5% | Dr. Reddy's Laboratories, Inc. | 2022-11-15 |
| 46708-0545-05 | 1 BOTTLE in 1 CARTON (46708-545-05) / 5 mL in 1 BOTTLE | Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% | Alembic Pharmaceuticals Limited | 2020-11-22 |
| 46708-0546-05 | 1 BOTTLE in 1 CARTON (46708-546-05) / 5 mL in 1 BOTTLE | Timolol Maleate Ophthalmic Gel Forming Solution, 0.5% | Alembic Pharmaceuticals Limited | 2020-11-22 |
| 59651-0313-05 | 1 BOTTLE, DISPENSING in 1 CARTON (59651-313-05) / 5 mL in 1... | TIMOLOL MALEATE | Aurobindo Pharma Limited | 2023-03-23 |
| 61314-0224-05 | 5 mL in 1 BOTTLE (61314-224-05) | Timolol GFS | Sandoz Inc | 1998-12-24 |
| 61314-0224-25 | 2.5 mL in 1 BOTTLE (61314-224-25) | Timolol GFS | Sandoz Inc | 1998-12-24 |
| 61314-0225-05 | 5 mL in 1 BOTTLE (61314-225-05) | Timolol GFS | Sandoz Inc | 1998-12-24 |
| 61314-0225-25 | 2.5 mL in 1 BOTTLE (61314-225-25) | Timolol GFS | Sandoz Inc | 1998-12-24 |
| 62332-0545-05 | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE | Timolol Maleate Ophthalmic Gel Forming Solution, 0.25% | Alembic Pharmaceuticals Inc. | 2020-11-22 |
| 62332-0546-05 | 1 BOTTLE in 1 CARTON (62332-546-05) / 5 mL in 1 BOTTLE | Timolol Maleate Ophthalmic Gel Forming Solution, 0.5% | Alembic Pharmaceuticals Inc. | 2020-11-22 |
| 68083-0457-01 | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE | timolol maleate ophthalmic gel forming solution | Gland Pharma Limited | 2022-06-24 |
| 68083-0458-01 | 1 BOTTLE in 1 CARTON (68083-458-01) / 5 mL in 1 BOTTLE | timolol maleate ophthalmic gel forming solution | Gland Pharma Limited | 2023-02-14 |
| 70069-0241-01 | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE | Timolol Maleate | Somerset Therapeutics, LLC | 2024-10-31 |
| 70069-0251-01 | 1 BOTTLE in 1 CARTON (70069-251-01) / 5 mL in 1 BOTTLE | Timolol Maleate | Somerset Therapeutics, LLC | 2024-10-31 |
| 72266-0199-01 | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE | Timolol Maleate Ophthalmic Gel Forming Solution | FOSUN PHARMA USA INC | 2022-09-26 |
| 72266-0200-01 | 1 BOTTLE in 1 CARTON (72266-200-01) / 5 mL in 1 BOTTLE | Timolol Maleate Ophthalmic Gel Forming Solution | FOSUN PHARMA USA INC | 2023-03-15 |
| 72603-0162-01 | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE | Timolol Maleate Ophthalmic Gel Forming Solution 0.25% | NorthStar RxLLC | 2023-08-14 |
| 72603-0163-01 | 1 BOTTLE in 1 CARTON (72603-163-01) / 5 mL in 1 BOTTLE | Timolol Maleate Ophthalmic Gel Forming Solution 0.5% | NorthStar RxLLC | 2023-08-14 |
| 82260-0818-25 | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1... | Timolol Maleate | Bausch & Lomb Americas Inc. | 2018-02-14 |
| 82260-0819-05 | 1 BOTTLE, DISPENSING in 1 CARTON (82260-819-05) / 5 mL in 1... | Timolol Maleate | Bausch & Lomb Americas Inc. | 2018-02-14 |
Observed labelers:
Sandoz Inc (4) ·
Alembic Pharmaceuticals Inc. (2) ·
Alembic Pharmaceuticals Limited (2) ·
Bausch & Lomb Americas Inc. (2) ·
Bausch & Lomb Incorporated (2) ·
Dr. Reddy's Laboratories, Inc. (2)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.